• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病和多系统萎缩中壳核多巴胺非去神经支配性耗竭的决定因素。

Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy.

作者信息

Goldstein David S, Sullivan Patti, Holmes Courtney, Mash Deborah C, Kopin Irwin J, Sharabi Yehonatan

机构信息

Clinical Neurocardiology Section, CNP/DIR/NINDS/NIH, Bethesda, MD 20892-1620, USA.

Clinical Neurocardiology Section, CNP/DIR/NINDS/NIH, Bethesda, MD 20892-1620, USA.

出版信息

Parkinsonism Relat Disord. 2017 Feb;35:88-91. doi: 10.1016/j.parkreldis.2016.12.011. Epub 2016 Dec 15.

DOI:10.1016/j.parkreldis.2016.12.011
PMID:28034624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319359/
Abstract

BACKGROUND

Severe putamen dopamine depletion characterizes Parkinson's disease (PD) and multiple system atrophy (MSA). The extent of the depletion is greater than can be accounted for by loss of nigrostriatal dopaminergic terminals alone. We used putamen tissue levels and ratios of cysteinyl and parent catechols to explore possible denervation-independent abnormalities of dopamine synthesis and fate in PD and MSA. 5-S-Cysteinyldopa (Cys-DOPA) is produced from spontaneous oxidation of DOPA and 5-S-cysteinyldopamine (Cys-DA) from spontaneous oxidation of DA.

METHODS

Post-mortem putamen tissue samples from 17 PD and 25 MSA patients and 30 controls were assayed for endogenous catechols including DA, its cytoplasmic metabolites (Cys-DA, 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxyphenylethanol, and 3,4-dihydroxyphenylacetaldehyde), and tyrosine hydroxylation products proximal to DA (DOPA and Cys-DOPA).

RESULTS

The PD and MSA groups did not differ in mean values of parent or cysteinyl catechols, and the data for the two groups were lumped. In the patients an index of vesicular storage of DA (the ratio of DA to the sum of its cytoplasmic metabolites) averaged 54% of control (p = 0.001), and an index of L-aromatic-amino-acid decarboxylase (LAAAD) activity (the ratio of DA and the sum of its cytoplasmic metabolites to the sum of DOPA + Cys-DOPA) averaged 21% of control (p < 0.0001). An index of innervation (the sum of DOPA + Cys-DOPA) averaged 63% of control (p = 0.01).

INTERPRETATION

Based on patterns of parent and cysteinyl catechols in putamen, PD and MSA involve decreased vesicular uptake and decreased LAAAD activity in the residual dopaminergic terminals. The combination seems to contribute importantly to dopamine depletion in these diseases.

摘要

背景

严重的壳核多巴胺耗竭是帕金森病(PD)和多系统萎缩(MSA)的特征。这种耗竭的程度大于仅由黑质纹状体多巴胺能终末丧失所能解释的程度。我们利用壳核组织中儿茶酚及其半胱氨酸衍生物的水平和比例,来探究PD和MSA中多巴胺合成及代谢可能存在的与去神经无关的异常情况。5-S-半胱氨酰多巴(Cys-DOPA)由多巴的自发氧化产生,5-S-半胱氨酰多巴胺(Cys-DA)由多巴胺的自发氧化产生。

方法

对17例PD患者、25例MSA患者及30例对照的尸检壳核组织样本进行检测,分析其中的内源性儿茶酚,包括多巴胺(DA)、其胞质代谢产物(Cys-DA、3,4-二羟基苯乙酸、3,4-二羟基苯乙醇及3,4-二羟基苯乙醛),以及DA上游的酪氨酸羟化产物(多巴和Cys-DOPA)。

结果

PD组和MSA组中儿茶酚及其半胱氨酸衍生物的平均值无差异,两组数据合并分析。患者中DA的囊泡储存指标(DA与其胞质代谢产物总和的比值)平均为对照组的54%(p = 0.001),L-芳香族氨基酸脱羧酶(LAAAD)活性指标(DA及其胞质代谢产物总和与多巴 + Cys-DOPA总和的比值)平均为对照组的21%(p < 0.0001)。神经支配指标(多巴 + Cys-DOPA总和)平均为对照组的63%(p = 0.01)。

解读

基于壳核中儿茶酚及其半胱氨酸衍生物的模式,PD和MSA涉及残余多巴胺能终末的囊泡摄取减少和LAAAD活性降低。这种组合似乎在这些疾病的多巴胺耗竭中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a48/6319359/2765eb3a6c80/nihms-989036-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a48/6319359/2765eb3a6c80/nihms-989036-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a48/6319359/2765eb3a6c80/nihms-989036-f0002.jpg

相似文献

1
Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy.帕金森病和多系统萎缩中壳核多巴胺非去神经支配性耗竭的决定因素。
Parkinsonism Relat Disord. 2017 Feb;35:88-91. doi: 10.1016/j.parkreldis.2016.12.011. Epub 2016 Dec 15.
2
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.帕金森病突触核蛋白病中脑脊液半胱氨酰多巴胺/3,4-二羟基苯乙酸比值升高。
Parkinsonism Relat Disord. 2016 Oct;31:79-86. doi: 10.1016/j.parkreldis.2016.07.009. Epub 2016 Jul 20.
3
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.多系统萎缩中囊泡储存和醛脱氢酶活性降低。
Parkinsonism Relat Disord. 2015 Jun;21(6):567-72. doi: 10.1016/j.parkreldis.2015.03.006. Epub 2015 Mar 20.
4
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.帕金森病中毒性多巴胺代谢物 DOPAL 蓄积的决定因素。
J Neurochem. 2013 Sep;126(5):591-603. doi: 10.1111/jnc.12345. Epub 2013 Jul 22.
5
Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.帕金森病患者多巴胺能脑区及非帕金森病老年人脑组织中多巴胺及相关儿茶酚的氧化。
J Neural Transm (Vienna). 2024 Mar;131(3):213-228. doi: 10.1007/s00702-023-02718-2. Epub 2024 Jan 18.
6
The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.采用正电子发射断层扫描(PET)研究多系统萎缩、单纯自主神经功能衰竭和帕金森病患者的运动功能障碍、自主神经功能障碍与纹状体多巴胺能系统完整性之间的关系。
Brain. 1990 Oct;113 ( Pt 5):1539-52. doi: 10.1093/brain/113.5.1539.
7
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.帕金森病患者尾状核和壳核中芳香族氨基酸脱羧酶(AADC)活性的耗竭;对正在进行的腺相关病毒2型-AADC基因治疗试验的启示。
PLoS One. 2017 Feb 6;12(2):e0169965. doi: 10.1371/journal.pone.0169965. eCollection 2017.
8
A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.帕金森病中心肌交感神经中囊泡隔离向氧化脱氨基转变。
J Neurochem. 2014 Oct;131(2):219-28. doi: 10.1111/jnc.12766. Epub 2014 Jun 13.
9
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.囊泡储存缺陷:儿茶酚胺能神经变性的一个共同主题。
Parkinsonism Relat Disord. 2015 Sep;21(9):1013-22. doi: 10.1016/j.parkreldis.2015.07.009. Epub 2015 Jul 17.
10
Brain monoamine systems in multiple system atrophy: a positron emission tomography study.多系统萎缩的脑单胺能系统:正电子发射断层扫描研究。
Neurobiol Dis. 2012 Apr;46(1):130-6. doi: 10.1016/j.nbd.2011.12.053. Epub 2012 Jan 12.

引用本文的文献

1
Uncovering the Associations of LILRB4 Genotypes With Parkinson's Disease: From Clinical Traits to Potential Pathologies.揭示LILRB4基因分型与帕金森病的关联:从临床特征到潜在病理机制
CNS Neurosci Ther. 2025 Jul;31(7):e70522. doi: 10.1111/cns.70522.
2
Relationship between Parkinson's disease and cardio-cerebrovascular diseases: a Mendelian randomized study.帕金森病与心脑血管疾病的关系:一项孟德尔随机研究。
Sci Rep. 2023 Nov 22;13(1):20428. doi: 10.1038/s41598-023-47708-2.
3
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease.

本文引用的文献

1
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.帕金森病突触核蛋白病中脑脊液半胱氨酰多巴胺/3,4-二羟基苯乙酸比值升高。
Parkinsonism Relat Disord. 2016 Oct;31:79-86. doi: 10.1016/j.parkreldis.2016.07.009. Epub 2016 Jul 20.
2
Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.单胺氧化酶抑制剂在降低PC12细胞中自毒性多巴胺代谢产物3,4-二羟基苯乙醛生成量方面的比较
J Pharmacol Exp Ther. 2016 Feb;356(2):483-92. doi: 10.1124/jpet.115.230201. Epub 2015 Nov 16.
3
二羟苯乙酮降低治疗可改善鱼藤酮诱导的大鼠运动和神经化学异常:与帕金森病发病机制的儿茶醛假说相关。
Int J Mol Sci. 2023 Aug 7;24(15):12522. doi: 10.3390/ijms241512522.
4
Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia.杂合 SPG11 c.1951C>T 和 SYNJ1 c.2614G>T 突变导致临床痉挛性截瘫患者热休克蛋白(hsp)-27 上调。
Genes (Basel). 2023 Jun 23;14(7):1320. doi: 10.3390/genes14071320.
5
Regional homogeneity and functional connectivity of freezing of gait conversion in Parkinson's disease.帕金森病中冻结步态转换的局部一致性和功能连接性
Front Aging Neurosci. 2023 Jul 12;15:1179752. doi: 10.3389/fnagi.2023.1179752. eCollection 2023.
6
Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons.中脑多巴胺氧化将谷胱甘肽过氧化物酶 4 的泛素化与多巴胺能神经元的铁死亡联系起来。
J Clin Invest. 2023 May 15;133(10):e165228. doi: 10.1172/JCI165228.
7
Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.帕金森病运动激活和抑制过程中的皮质振荡功能障碍。
PLoS One. 2022 Mar 4;17(3):e0257711. doi: 10.1371/journal.pone.0257711. eCollection 2022.
8
The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease.该鼠鱼藤酮模型再现了帕金森病中发现的中枢儿茶酚胺代谢异常模式。
Dis Model Mech. 2022 Jan 1;15(1). doi: 10.1242/dmm.049082. Epub 2022 Jan 24.
9
Altered Spontaneous Neural Activity and Functional Connectivity in Parkinson's Disease With Subthalamic Microlesion.伴有丘脑底核微病灶的帕金森病患者自发神经活动和功能连接的改变
Front Neurosci. 2021 Jul 20;15:699010. doi: 10.3389/fnins.2021.699010. eCollection 2021.
10
The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.将“病态但非死亡”现象应用于神经退行性疾病中的儿茶酚胺缺乏症。
Semin Neurol. 2020 Oct;40(5):502-514. doi: 10.1055/s-0040-1713874. Epub 2020 Sep 9.
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
多系统萎缩中囊泡储存和醛脱氢酶活性降低。
Parkinsonism Relat Disord. 2015 Jun;21(6):567-72. doi: 10.1016/j.parkreldis.2015.03.006. Epub 2015 Mar 20.
4
Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.帕金森病是一种囊泡多巴胺储存障碍疾病吗?来自一项对人类和非人类灵长类动物纹状体分离突触囊泡研究的证据。
J Neurosci. 2014 Jun 11;34(24):8210-8. doi: 10.1523/JNEUROSCI.5456-13.2014.
5
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.帕金森病中毒性多巴胺代谢物 DOPAL 蓄积的决定因素。
J Neurochem. 2013 Sep;126(5):591-603. doi: 10.1111/jnc.12345. Epub 2013 Jul 22.
6
Incidental Lewy body disease and preclinical Parkinson disease.偶发性路易体病和临床前帕金森病。
Arch Neurol. 2008 Aug;65(8):1074-80. doi: 10.1001/archneur.65.8.1074.
7
Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.帕金森病死后大脑的生物化学:历史概述与未来展望
J Neural Transm Suppl. 2007(72):113-20. doi: 10.1007/978-3-211-73574-9_14.
8
Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.苄丝肼可降低大鼠纹状体中脑内芳香族氨基酸脱羧酶(AADC)的活性、细胞外多巴胺水平及左旋多巴脱羧作用。
J Neural Transm (Vienna). 2001;108(5):559-70. doi: 10.1007/s007020170056.
9
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.特发性帕金森病患者纹状体中多巴胺丧失的不均匀模式。病理生理学及临床意义。
N Engl J Med. 1988 Apr 7;318(14):876-80. doi: 10.1056/NEJM198804073181402.
10
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.帕金森病中免疫组化鉴定的脑干神经元的神经病理学
Ann Neurol. 1990 Apr;27(4):373-85. doi: 10.1002/ana.410270405.